India Business News

Investors placed bids for 969 million shares in the Vidya Wires IPO, compared with the 43.33 million shares available, translating to a subscription level of 22.35 times

Lupin announced that it has received tentative approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Siponimod Tablets in 0.25 mg, 1 mg and 2 mg.

At the AWS re:Invent 2025 Partner Awards Gala, partners were recognized for their specialization, innovation, and collaboration, and for evolving business models that enable success on AWS while supporting their customers.

For commercialization and distribution of Armlupeg in US market

Vivid Mercantile Ltd, Hisar Metal Industries Ltd, DJ Mediaprint & Logistics Ltd and TGB Banquets & Hotels Ltd are among the other losers in the BSE's 'B' group today, 04 December 2025.

Lupin announced that it has entered into an exclusive licensing agreement with U.S.-based biosimilar specialist Valorum Biologics for its biosimilar Armlupeg (pegfilgrastim-unne).

Outside Parliament, senior Opposition leaders including Rahul Gandhi, Sonia Gandhi and Priyanka Gandhi staged a demonstration seeking a rollback of the SIR exercise. Union Parliamentary Affairs Minister Kiren Rijiju criticised the protests, arguing

Recently listed eyewear retailer Lenskart posted a nearly 20 per cent year-on-year (Y-o-Y) jump in net profit for the September quarter, reaching ₹103.5 crore

The product will be manufactured at Lupin's Biotech facility in Pune, which was inspected by the U.S. FDA prior to approval.